Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
Cart
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Home
Journals
Revista Romana de Medicina de Laborator
Volume 21 (2013): Issue 1 (March 2013)
Open Access
Tyrosine kinase inhibitor treatment outcome in a single center cohort of chronic myeloid leukemia patients. The role of the T315I ABL kinase domain mutation
Delia Dima
Delia Dima
,
Adrian P. Trifa
Adrian P. Trifa
,
Mariana Paţiu
Mariana Paţiu
,
Cristian S. Vesa
Cristian S. Vesa
,
Ioana C. Frinc
Ioana C. Frinc
,
Ljubomir Petrov
Ljubomir Petrov
and
Andrei Cucuianu
Andrei Cucuianu
| Aug 08, 2013
Revista Romana de Medicina de Laborator
Volume 21 (2013): Issue 1 (March 2013)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Aug 08, 2013
Page range:
29 - 37
DOI:
https://doi.org/10.2478/rrlm-2013-0015
This content is open access.
Delia Dima
“Ion Chiricuţa ” Cancer Institute Cluj-Napoca, Hematology Department
Adrian P. Trifa
University of Medicine and Pharmacy “Iuliu Haţieganu ” Cluj-Napoca, Genetics Department
Mariana Paţiu
“Ion Chiricuţa ” Cancer Institute Cluj-Napoca, Hematology Department
Cristian S. Vesa
University of Medicine and Pharmacy “Iuliu Haţieganu ” Cluj-Napoca, Medical Pharmacology Department
Ioana C. Frinc
“Ion Chiricuţa ” Cancer Institute Cluj-Napoca, Hematology Department
Ljubomir Petrov
“Ion Chiricuţa ” Cancer Institute Cluj-Napoca, Hematology Department
Andrei Cucuianu
“Ion Chiricuţa ” Cancer Institute Cluj-Napoca, Hematology Department 73, 21 Decembrie 1989 Bvd, 400124, Cluj-Napoca